Deutsche Bank AG Reiterates €60.00 Price Target for Compugroup Medical SE (COP)
Compugroup Medical SE (ETR:COP) has been assigned a €60.00 ($70.59) price target by Deutsche Bank AG in a report issued on Monday. The firm presently has a “buy” rating on the stock.
Several other equities analysts also recently commented on the stock. Berenberg Bank set a €53.00 ($62.35) target price on shares of Compugroup Medical SE and gave the stock a “neutral” rating in a report on Friday. Warburg Research set a €52.00 ($61.18) price target on shares of Compugroup Medical SE and gave the company a “neutral” rating in a research note on Thursday. Baader Bank set a €52.00 ($61.18) price target on shares of Compugroup Medical SE and gave the company a “buy” rating in a research note on Thursday. Finally, HSBC Holdings plc set a €60.00 ($70.59) target price on shares of Compugroup Medical SE and gave the company a “buy” rating in a research note on Wednesday, July 5th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of €55.40 ($65.18).
Shares of Compugroup Medical SE (COP) opened at 47.284 on Monday. The stock has a market capitalization of €2.35 billion and a PE ratio of 49.825. The company’s 50 day moving average is €50.49 and its 200-day moving average is €44.26. Compugroup Medical SE has a 52 week low of €36.21 and a 52 week high of €52.80.
About Compugroup Medical SE
Compugroup Medical SE is a Germany-based software developer. The Company focuses on software solutions to the healthcare industry, including physicians, pharmacies, health insurances, laboratories, hospitals and rehabilitation and care facilities. Its activities are divided into three segments: Health Provider Services I, Health Provider Services II and Health Connectivity Services.
Receive News & Ratings for Compugroup Medical SE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical SE and related companies with MarketBeat.com's FREE daily email newsletter.